当前位置:首页 > 报告详情

0920_Parodi.pdf

上传人: 明**** 编号:1012211 2025-12-21 37页 1.80MB

1、Expanding Endovascular Options for Treatment of Arch PathologyF.Ezequiel Parodi MDAssociate Professor UNCDisclosures Centerline Biomedical:Consultant,Stock options Cook Medical:Research support,Training Gore:ConsultantProblems Unique to the Arch Increased pressure and migration forces Coronary Arter

2、ies Dealing with the aortic valve and working in LV Need for overdrive pacing for deploymentAortic Arch-Debranching-Laser-Branch/FenestratedDebranching+TEVAR Numerous options available for hybrid procedures Carotid-Subclavian bypass Carotid-Carotid bypass Ascending arch based bypassesGreat Vessel In

3、volvement Most commonly requires coverage of the L SCA Most patients can tolerate L SCA covering without pre-operative revascularization Exceptions LIMA L Vertebral arising from the arch LUE AV fistula Dominant L vertebral artery Vertebral ends in PICA L SCA should be revascularized in elective surg

4、eryL CCAClip Retrospective review of 60 patients Complicated type B dissections,Ruptures,IMH and Chronic dissections Zone 0 in 2 patients,Zone 1 in 5 and Zone 2 in 51 patientsResults Mean follow up 2.44 years In hospital Morality 8.3%Stroke rate 3.3%100%primary patency on follow up Three type IC end

5、oleaks requiring re interventionConclusion:Laser fenestration is a durable,has high technical success and primary patency with low re intervention rate 1011In-Situ Laser fenestration121314GORE TBETBE DeviceAortic ComponentSide Branch(SB)ComponentAortic Extender1617L radial access.4Fr 75cm sheathN=40

6、,Male 52%9 Patients zone 0/1 31 Patients zone 2No device migration,fracture,or ruptureTwo side branch occlusions,both on zone 2Freedom from re-intervention 97%zone 2,100%zone 0/1Endoleaks I&IIIOne type 1A treated with another TBE to Zone 0One type III not treatedTwo strokesEur J Vasc Endovasc Surg 2

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,全文主要探讨了主动脉弓病变的血管内治疗新选项。以下是关键点: 1. 主动脉弓病变治疗面临挑战,如压力增加、移位力、冠状动脉处理、瓣膜和左心室操作等。 2. 混合手术有多种选择,包括颈动脉-锁骨下动脉旁路、颈动脉-颈动脉旁路和升主动脉弓旁路。 3. 大血管受累通常需要覆盖左侧锁骨下动脉(LSCA),大多数患者无需术前再血管化。 4. 激光窗孔技术具有耐用性、高技术成功率和低再干预率。 5. GORE TBETBE装置在40名患者中应用,无装置移位、断裂或破裂,97%的2区患者和100%的0/1区患者无再干预。 6. Nexus平台在28名患者中应用,100%手术成功,30天死亡率为7.1%,卒中率为3.6%。 7. Cook a Branch在39名患者中应用,100%技术成功,5%住院死亡率和5%卒中率。 8. 新技术具有前景,但需要熟练的技术、患者选择和计划,且手术卒中仍是一个重要问题,需要更长期的结果来评估耐用性。
"动脉病变治疗新选择" 技术成功与挑战" 未来展望与挑战"
客服
商务合作
小程序
服务号
折叠